Globus Medical, Inc. (NYSE:GMED) Receives $66.11 Consensus PT from Analysts

Globus Medical, Inc. (NYSE:GMED – Get Free Report) has been assigned a consensus recommendation of “Hold” from the twelve analysts that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating on […]

Leave a Reply

Your email address will not be published.

Previous post Brookfield Infrastructure Partners L.P. (NYSE:BIP) Receives $38.44 Consensus Price Target from Analysts
Next post A healthy start: 4 recipes to help you keep those 2024 resolutions